share_log

4: Statement of changes in beneficial ownership of securities-Director Farley Chele Chiavacci

4: Statement of changes in beneficial ownership of securities-Director Farley Chele Chiavacci

4：持股變動聲明-董事 Farley Chele Chiavacci
美股SEC公告 ·  06/12 05:58
牛牛AI助理已提取核心訊息
Conduit Pharmaceuticals Inc. (CDT.US) reported that Farley Chele Chiavacci, acquired 37,272 shares of common stock on June 11, 2024. The transaction was coded as 'A', indicating a grant, award, or other acquisition. Following this transaction, Chiavacci's direct holdings in the company total 52,272 shares. The acquisition was executed with the shares being held directly by Chiavacci, as per the filing details. The transaction underscores a positive movement in the insider's stake in the company, which can be an indicator of the company's future prospects.
Conduit Pharmaceuticals Inc. (CDT.US) reported that Farley Chele Chiavacci, acquired 37,272 shares of common stock on June 11, 2024. The transaction was coded as 'A', indicating a grant, award, or other acquisition. Following this transaction, Chiavacci's direct holdings in the company total 52,272 shares. The acquisition was executed with the shares being held directly by Chiavacci, as per the filing details. The transaction underscores a positive movement in the insider's stake in the company, which can be an indicator of the company's future prospects.
Conduit Pharmaceuticals Inc.（CDT.US）報告Farley Chele Chiavacci於2024年6月11日收購了37,272股普通股。該交易編碼爲“A”，表示授予、獎勵或其他獲取。在此次交易後，Chiavacci在公司的直接持股總計爲52,272股。根據申報細節，該收購行爲是由Chiavacci直接持有這些股票進行的。這一交易強調內部人員持股正向變化，這可能是公司未來前景的一個指標。
Conduit Pharmaceuticals Inc.（CDT.US）報告Farley Chele Chiavacci於2024年6月11日收購了37,272股普通股。該交易編碼爲“A”，表示授予、獎勵或其他獲取。在此次交易後，Chiavacci在公司的直接持股總計爲52,272股。根據申報細節，該收購行爲是由Chiavacci直接持有這些股票進行的。這一交易強調內部人員持股正向變化，這可能是公司未來前景的一個指標。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。